Time of morulation and trophectoderm quality are predictors of a live birth after euploid blastocyst transfer: a multicenter study.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
12 2019
Historique:
received: 04 06 2019
revised: 11 07 2019
accepted: 22 07 2019
entrez: 18 12 2019
pubmed: 18 12 2019
medline: 27 5 2020
Statut: ppublish

Résumé

To investigate whether the morphodynamic characterization of a euploid blastocyst's development allows a higher prediction of a live birth after single-embryo-transfer (SET). Observational cohort study conducted in two phases: training and validation. Private in vitro fertilization centers. Euploid blastocysts: 511 and 319 first vitrified-warmed SETs from 868 and 546 patients undergoing preimplantation genetic testing for aneuploidies (PGT-A) in the training and validation phase, respectively. Data collected from time of polar body extrusion to time of starting blastulation, and trophectoderm and inner-cell-mass static morphology in all embryos cultured in a specific time-lapse incubator with a continuous medium. Logistic regressions conducted to outline the variables showing a statistically significant association with live birth. In the validation phase, these variables were tested in an independent data set. Live births per SET. The average live birth rate (LBR) in the training set was 40% (N = 207/511). Only time of morulation (tM) and trophectoderm quality were outlined as putative predictors of live birth at two IVF centers. In the validation set, the euploid blastocysts characterized by tM <80 hours and high-quality trophectoderm resulted in a LBR of 55.2% (n = 37/67), while those with tM ≥ 80 hours and a low-quality trophectoderm resulted in a LBR of 25.5% (N = 13/51). Time of morulation and trophectoderm quality are better predictors of a euploid blastocyst's reproductive competence. Our evidence was reproducible across different centers under specific culture conditions. These data support the crucial role of morulation for embryo development, a stage that involves massive morphologic, cellular, and molecular changes and deserves more investigation.

Identifiants

pubmed: 31843084
pii: S0015-0282(19)31930-2
doi: 10.1016/j.fertnstert.2019.07.1322
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1080-1093.e1

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Laura Rienzi (L)

Clinica Valle Giulia, G.EN.E.R.A. Centers for Reproductive Medicine, Rome, Italy. Electronic address: rienzi@generaroma.it.

Danilo Cimadomo (D)

Clinica Valle Giulia, G.EN.E.R.A. Centers for Reproductive Medicine, Rome, Italy.

Arantxa Delgado (A)

IVI-RMA, Valencia, Spain.

Maria Giulia Minasi (MG)

Center for Reproductive Medicine, European Hospital, Rome, Italy.

Gemma Fabozzi (G)

Clinica Valle Giulia, G.EN.E.R.A. Centers for Reproductive Medicine, Rome, Italy.

Raquel Del Gallego (RD)

IVI-RMA, Valencia, Spain.

Marta Stoppa (M)

Clinica Valle Giulia, G.EN.E.R.A. Centers for Reproductive Medicine, Rome, Italy.

Jose Bellver (J)

IVI-RMA, Valencia, Spain.

Adriano Giancani (A)

Clinica Valle Giulia, G.EN.E.R.A. Centers for Reproductive Medicine, Rome, Italy; DAHFMO, Unit of Histology and Medical Embryology, "Sapienza" University of Rome, Italy.

Marga Esbert (M)

IVI-RMA, Barcelona, Spain.

Antonio Capalbo (A)

DAHFMO, Unit of Histology and Medical Embryology, "Sapienza" University of Rome, Italy; Igenomix, Marostica, Italy.

Jose Remohì (J)

IVI-RMA, Valencia, Spain.

Ermanno Greco (E)

Center for Reproductive Medicine, European Hospital, Rome, Italy.

Filippo Maria Ubaldi (FM)

Clinica Valle Giulia, G.EN.E.R.A. Centers for Reproductive Medicine, Rome, Italy.

Marcos Meseguer (M)

IVI-RMA, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH